Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SH3YL1 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
mRNA | CAPRIN2 | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
mRNA | SLC35F3 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
mRNA | S100A9 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
mRNA | STX19 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
mRNA | CTHRC1 | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
mRNA | WDR13 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
mRNA | PRICKLE1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | SYT13 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | HNF1B | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |